Immunotherapy in Metastatic NSCLC – OncLive
OncLive |
Immunotherapy in Metastatic NSCLC
OncLive Solange Peters, MD, PhD: Before PACIFIC was performed, immunotherapy had already kind of reached the level of standard of care in advanced disease. In the recent 5 years, I would say in lung cancer—a little bit longer in melanoma; maybe 10 years in … |
